Remicade is a common medicine used for the treatment of inflammatory bowel disease. This
medication is given as an intravenous infusion over 2 hours. Studies have suggested it is
safe to give the infusion at a faster rate. The investigators would like to see if the
infusion can be given over 1 hour. The investigators expect that increasing the rate of
infusion WILL NOT lead to an increase in infusion reactions and will be just as safe and
effective as the standard 2 hours dose.